BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castellaneta A, Massaro A, Rendina M, D'Errico F, Carparelli S, Rizzi SF, Thomson AW, Di Leo A. Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence. Transplant Res 2016;5:1. [PMID: 26798454 DOI: 10.1186/s13737-016-0030-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sohrabi MJ, Dehpour AR, Attar F, Hasan A, Mohammad-Sadeghi N, Meratan AA, Aziz FM, Salihi A, Shekha MS, Akhtari K, Shahpasand K, Hojjati SMM, Sharifi M, Saboury AA, Rezayat SM, Mousavi SE, Falahati M. Silymarin-albumin nanoplex: Preparation and its potential application as an antioxidant in nervous system in vitro and in vivo. Int J Pharm 2019;572:118824. [PMID: 31715345 DOI: 10.1016/j.ijpharm.2019.118824] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
2 Tong WW, Zhang C, Hong T, Liu DH, Wang C, Li J, He XK, Xu WD. Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats. Sci Rep 2018;8:3241. [PMID: 29459717 DOI: 10.1038/s41598-018-21674-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
3 Jiang M, He K, Qiu T, Sun J, Liu Q, Zhang X, Zheng H. Tumor-targeted delivery of silibinin and IPI-549 synergistically inhibit breast cancer by remodeling the microenvironment. Int J Pharm 2020;581:119239. [PMID: 32194211 DOI: 10.1016/j.ijpharm.2020.119239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]